All of the presenters come together as a panel to take wide ranging audience questions.
Introducing Dr. Sebastian Unizony, M.D. | 4:38 |
An overview of GCA. | 6:25 |
How does GCA commonly present? | 7:08 |
How is GCA diagnosed? | 9:15 |
How is GCA typically treated? | 12:22 |
Initial attempts to find a steroid-sparing option. | 13:37 |
Tozilizumab (TCZ+Actemra) The GiACTA study | 14:09 |
Standard of care treatment recommendations | 16:31 |
Several promising targets being explored. | 21:30 |
Mavrilimumab for GCA | 22:42 |
Ongoing study of upadacitinib (rinvoq) | 23:39 |
Q &A | 24:27 |
All of the presenters come together as a panel to take wide ranging audience questions.
Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives.
The Vasculitis Foundation is a registered 501 (c) (3) non-profit organization. All contributions are 100% tax-deductible.
Click here to send us an email!
Mail:
Vasculitis Foundation
PO Box 28660
Kansas City, MO 64188
1.816.436.8211 or 1.800.277.9474
All Rights Reserved